Just diagnosed with Glycine encephalopathy?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Glycine encephalopathy, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Glycine encephalopathy hub →Overview
Glycine encephalopathy is a rare condition. Also known as NKA, Non-ketotic hyperglycinemia. Tomeko brings together the specialists, research, clinical trials, treatments and community for Glycine encephalopathy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:407 · OMIM 605899, 620398, 620423 · ICD-10 E72.5 · GARD 0007219
Find care for Glycine encephalopathy
Authoritative references for Glycine encephalopathy
Research & market landscape for Glycine encephalopathy
Following Glycine encephalopathy for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Glycine encephalopathy — the real-world landscape behind the condition, in one place.
- Latest Glycine encephalopathy research on PubMed ↗
- Recruiting Glycine encephalopathy trials on ClinicalTrials.gov ↗
- Explore the Glycine encephalopathy research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Glycine encephalopathy and every rare condition. See how Tomeko works with industry →
Common questions
What is Glycine encephalopathy?
Glycine encephalopathy is a rare condition. Also known as NKA, Non-ketotic hyperglycinemia. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Glycine encephalopathy together in one place.
What are the symptoms of Glycine encephalopathy?
Symptoms of Glycine encephalopathy vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Glycine encephalopathy.
How is Glycine encephalopathy treated?
Treatment for Glycine encephalopathy depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Glycine encephalopathy, and review current options with them.
What causes Glycine encephalopathy — is it genetic?
The cause and inheritance of Glycine encephalopathy are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Glycine encephalopathy can explain what it means for you and your family.
I was just diagnosed with Glycine encephalopathy — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Glycine encephalopathy, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Glycine encephalopathy?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Glycine encephalopathy, filtered to your area.
Are there clinical trials for Glycine encephalopathy?
Tomeko shows live, recruiting studies for Glycine encephalopathy from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3